PAPER Matsui Y, Satoh K, Miyazaki T, Shirabe S, Atarashi R, Mutsukura K, Satoh A, Kataoka Y, Nishida N
SEARCH RESULTS
330913 RESULTS
PAPER
Syncope with cholinesterase inhibitors.
BMC Geriatr. 2011;11:58. PubMed: 21970087PAPER Andersen F, Viitanen M, Halvorsen DS, Straume B, Engstad TA
Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the Dementia Study in Northern Norway.
BMC Geriatr. 2011;11:58. PubMed: 21970467PAPER Zuliani G, Donnorso MP, Bosi C, Passaro A, Dalla Nora E, Zurlo A, Bonetti F, Mozzi AF, Cortese C
Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.
BMC Neurol. 2011;11:121. PubMed: 21970714PAPER Naoi M, Maruyama W, Inaba-Hasegawa K, Akao Y
Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection.
Int Rev Neurobiol. 2011;100:85-106. PubMed: 21971004PAPER Weinreb O, Amit T, Bar-Am O, Youdim MB
A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor.
Int Rev Neurobiol. 2011;100:191-215. PubMed: 21971009PAPER Van der Schyf CJ, Geldenhuys WJ
Multimodal drugs and their future for Alzheimer's and Parkinson's disease.
Int Rev Neurobiol. 2011;100:107-25. PubMed: 21971005PAPER Wexler EM, Rosen E, Lu D, Osborn GE, Martin E, Raybould H, Geschwind DH
Genome-wide analysis of a Wnt1-regulated transcriptional network implicates neurodegenerative pathways.
Sci Signal. 2011 Oct 4;4(193):ra65. PubMed: 21971039PAPER Jing F, Mogi M, Sakata A, Iwanami J, Tsukuda K, Ohshima K, Min LJ, Steckelings UM, Unger T, Dahlöf B, Horiuchi M
Direct stimulation of angiotensin II type 2 receptor enhances spatial memory.
J Cereb Blood Flow Metab. 2011 Oct 5; PubMed: 21971355PAPER Chapuis J, Vingtdeux V, Capiralla H, Davies P, Marambaud P
Gas1 Interferes with AβPP Trafficking by Facilitating the Accumulation of Immature AβPP in Endoplasmic Reticulum-Associated Raft Subdomains.
J Alzheimers Dis. 2012 Jan 1;28(1):127-35. PubMed: 21971401PAPER Insua D, Corredoira A, González-Martínez A, Suárez ML, Santamarina G, Sarasa M, Pesini P
Expression of p75NTR, a Marker for Basal Forebrain Cholinergic Neurons, in Young and Aged Dogs with or without Cognitive Dysfunction Syndrome.
J Alzheimers Dis. 2011 Oct 4; PubMed: 21971402PAPER Lewczuk P, Popp J, Lelental N, Kölsch H, Maier W, Kornhuber J, Jessen F
Cerebrospinal Fluid Soluble Amyloid-β Protein Precursor as a Potential Novel Biomarkers of Alzheimer's Disease.
J Alzheimers Dis. 2012 Jan 1;28(1):119-25. PubMed: 21971403PAPER Gallagher JJ, Finnegan ME, Grehan B, Dobson J, Collingwood JF, Lynch MA
Modest Amyloid Deposition is Associated with Iron Dysregulation, Microglial Activation, and Oxidative Stress.
J Alzheimers Dis. 2012 Jan 1;28(1):147-61. PubMed: 21971404PAPER Baker LD, Bayer-Carter JL, Skinner J, Montine TJ, Cholerton BA, Callaghan M, Leverenz JB, Walter BK, Tsai E, Postupna N, Lampe J, Craft S
High-Intensity Physical Activity Modulates Diet Effects on Cerebrospinal Amyloid-β Levels in Normal Aging and Mild Cognitive Impairment.
J Alzheimers Dis. 2012;28(1):137-46. PubMed: 21971406PAPER Kaneai N, Arai M, Takatsu H, Fukui K, Urano S
Vitamin e inhibits oxidative stress-induced denaturation of nerve terminal proteins involved in neurotransmission.
J Alzheimers Dis. 2012;28(1):183-9. PubMed: 21971407Current Filters
No filters selected